The recommended treatment of grade 3 giant
cell tumor of bone (grade 3 GCTB) aims to eliminate tumor and conserve limb
with extended intralesional curettage.
This treatment
makes patients better function of bone and joint as usual. Even
it can reduce postoperative complications and replace endoprosthesis. Still,
there is limited information about the outcomes of surgical treatment and
recurrence of the disease.
This study aimed to evaluate the clinical
outcomes and recurrence of grade 3 GCTB with extended intralesional curettage.
No comments:
Post a Comment